These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 19223399)

  • 1. Dysregulation of glucocorticoid metabolism in murine obesity: comparable effects of leptin resistance and deficiency.
    Livingstone DE; Grassick SL; Currie GL; Walker BR; Andrew R
    J Endocrinol; 2009 May; 201(2):211-8. PubMed ID: 19223399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leptin activation of corticosterone production in hepatocytes may contribute to the reversal of obesity and hyperglycemia in leptin-deficient ob/ob mice.
    Liu Y; Nakagawa Y; Wang Y; Li R; Li X; Ohzeki T; Friedman TC
    Diabetes; 2003 Jun; 52(6):1409-16. PubMed ID: 12765951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploring the endocannabinoidome in genetically obese (ob/ob) and diabetic (db/db) mice: Links with inflammation and gut microbiota.
    Suriano F; Manca C; Flamand N; Depommier C; Van Hul M; Delzenne NM; Silvestri C; Cani PD; Di Marzo V
    Biochim Biophys Acta Mol Cell Biol Lipids; 2022 Jan; 1867(1):159056. PubMed ID: 34606993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cholesterol metabolism and Cx43, Cx46, and Cx50 gap junction protein expression and localization in normal and diabetic and obese ob/ob and db/db mouse testes.
    Pelletier RM; Akpovi CD; Chen L; Vitale ML
    Am J Physiol Endocrinol Metab; 2018 Jan; 314(1):E21-E38. PubMed ID: 28851737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adiponectin homolog novel osmotin protects obesity/diabetes-induced NAFLD by upregulating AdipoRs/PPARα signaling in ob/ob and db/db transgenic mouse models.
    Ahmad A; Ali T; Kim MW; Khan A; Jo MH; Rehman SU; Khan MS; Abid NB; Khan M; Ullah R; Jo MG; Kim MO
    Metabolism; 2019 Jan; 90():31-43. PubMed ID: 30473057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel genetically-obese rat model with elevated 11 beta-hydroxysteroid dehydrogenase type 1 activity in subcutaneous adipose tissue.
    Prasad SS; Prashanth A; Kumar CP; Reddy SJ; Giridharan NV; Vajreswari A
    Lipids Health Dis; 2010 Nov; 9():132. PubMed ID: 21083914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Up-regulation of peroxisome proliferator-activated receptors (PPAR-alpha) and PPAR-gamma messenger ribonucleic acid expression in the liver in murine obesity: troglitazone induces expression of PPAR-gamma-responsive adipose tissue-specific genes in the liver of obese diabetic mice.
    Memon RA; Tecott LH; Nonogaki K; Beigneux A; Moser AH; Grunfeld C; Feingold KR
    Endocrinology; 2000 Nov; 141(11):4021-31. PubMed ID: 11089532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Skeletal glucocorticoid signalling determines leptin resistance and obesity in aging mice.
    Henneicke H; Kim S; Swarbrick MM; Li J; Gasparini SJ; Thai J; Foong D; Cavanagh LL; Fong-Yee C; Karsten E; Lin RCY; Cooper MS; Zhou H; Seibel MJ
    Mol Metab; 2020 Dec; 42():101098. PubMed ID: 33045434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of gonadectomy on glucocorticoid metabolism in obese Zucker rats.
    Barat P; Livingstone DE; Elferink CM; McDonnell CR; Walker BR; Andrew R
    Endocrinology; 2007 Oct; 148(10):4836-43. PubMed ID: 17628001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term and rapid regulation of ob mRNA levels in adipose tissue from normal (Sprague Dawley rats) and obese (db/db mice, fa/fa rats) rodents.
    Igel M; Kainulainen H; Brauers A; Becker W; Herberg L; Joost HG
    Diabetologia; 1996 Jul; 39(7):758-65. PubMed ID: 8817099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leptin signalling regulates transcriptional differences in granulosa cells from genetically obese mice but not the activation of NLRP3 inflammasome.
    Adamowski M; Sharma Y; Molcan T; Wołodko K; Kelsey G; Galvão AM
    Sci Rep; 2024 Apr; 14(1):8070. PubMed ID: 38580672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced adipose glucocorticoid reactivation and increased hepatic glucocorticoid clearance as an early adaptation to high-fat feeding in Wistar rats.
    Drake AJ; Livingstone DE; Andrew R; Seckl JR; Morton NM; Walker BR
    Endocrinology; 2005 Feb; 146(2):913-9. PubMed ID: 15550507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multihormonal control of ob gene expression and leptin secretion from cultured human visceral adipose tissue: increased responsiveness to glucocorticoids in obesity.
    Halleux CM; Servais I; Reul BA; Detry R; Brichard SM
    J Clin Endocrinol Metab; 1998 Mar; 83(3):902-10. PubMed ID: 9506746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel insights into the genetically obese (ob/ob) and diabetic (db/db) mice: two sides of the same coin.
    Suriano F; Vieira-Silva S; Falony G; Roumain M; Paquot A; Pelicaen R; Régnier M; Delzenne NM; Raes J; Muccioli GG; Van Hul M; Cani PD
    Microbiome; 2021 Jun; 9(1):147. PubMed ID: 34183063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Obese and diabetic db/db mice develop marked liver fibrosis in a model of nonalcoholic steatohepatitis: role of short-form leptin receptors and osteopontin.
    Sahai A; Malladi P; Pan X; Paul R; Melin-Aldana H; Green RM; Whitington PF
    Am J Physiol Gastrointest Liver Physiol; 2004 Nov; 287(5):G1035-43. PubMed ID: 15256362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In obese mice, exercise training increases 11β-HSD1 expression, contributing to glucocorticoid activation and suppression of pulmonary inflammation.
    Du SF; Yu Q; Chuan K; Ye CL; He ZJ; Liu SJ; Zhu XY; Liu YJ
    J Appl Physiol (1985); 2017 Oct; 123(4):717-727. PubMed ID: 28663379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of expression of ob mRNA and protein by glucocorticoids and cAMP.
    Slieker LJ; Sloop KW; Surface PL; Kriauciunas A; LaQuier F; Manetta J; Bue-Valleskey J; Stephens TW
    J Biol Chem; 1996 Mar; 271(10):5301-4. PubMed ID: 8621378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tissue-specific glucocorticoid reactivating enzyme, 11 beta-hydroxysteroid dehydrogenase type 1 (11 beta-HSD1)--a promising drug target for the treatment of metabolic syndrome.
    Masuzaki H; Flier JS
    Curr Drug Targets Immune Endocr Metabol Disord; 2003 Dec; 3(4):255-62. PubMed ID: 14683456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological evaluation of adipose dysfunction via 11β-hydroxysteroid dehydrogenase type 1 in the development of diabetes in diet-induced obese mice with cortisone pellet implantation.
    Akiyama N; Akiyama Y; Kato H; Kuroda T; Ono T; Imagawa K; Asakura K; Shinosaki T; Murayama T; Hanasaki K
    J Pharmacol Exp Ther; 2014 Apr; 349(1):66-74. PubMed ID: 24511146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of Obesity and Leptin Deficiency on Morphine Pharmacokinetics in a Mouse Model.
    Dalesio NM; Hendrix CW; McMichael DH; Thompson CB; Lee CK; Pho H; Arias RS; Lynn RR; Galinkin J; Yaster M; Brown RH; Schwartz AR
    Anesth Analg; 2016 Dec; 123(6):1611-1617. PubMed ID: 27782940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.